ESR1 and breast cancer: The EXPERT (Examining Personalized Radiation Therapy for Low Risk Early Breast Cancer) trial is a Phase III randomized trial evaluating the omission of breast radiation in ER+/Her-2 negative early stage breast cancers with PAM-50 ROR < 60 in women ≥ 50 yo [79].